RGNX
Regenxbio Inc
NASDAQ · Biotechnology
$10.33
+0.07 (+0.68%)
Open$10.73
Previous Close$10.26
Day High$10.95
Day Low$10.32
52W High$16.19
52W Low$5.04
Volume—
Avg Volume1.35M
Market Cap522.94M
P/E Ratio—
EPS$-3.46
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+78.9% upside
Current
$10.33
$10.33
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 85.20M | 151.69M | 90.45M |
| Net Income | -232,213,149 | -372,070,204 | 17.14M |
| Profit Margin | -272.5% | -258.9% | 19.0% |
| EBITDA | -221,096,320 | -373,938,942 | 30.51M |
| Free Cash Flow | — | — | 17.02M |
| Rev Growth | -43.8% | -43.8% | +14.5% |
| Debt/Equity | — | — | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |